Orthofix said it will consolidate behind its strongest commercial distributors, while also simplifying its portfolio and ...

The Swiss developer disclosed that the agency deemed its premarket application for the Optune Mya system as not approvable.

Dr. Stacy Beske will take over as president starting Dec. 1 for Elin Frostehav, who is leaving Getinge to become CEO of ...

The Vitalyst system is a miniature heart pump designed to treat acute myocardial infarction cardiogenic shock.

Smith+Nephew’s CEO confirmed this week that talks failed with Johnson & Johnson over an orthopedic megamerger with DePuy ...

The medtech developer exceeded Wall Street expectations across the board, reporting $19.5 billion in revenue for fiscal year ...

At the TCT conference in San Diego, Medtronic and Recor Medical presented new findings from their rival treatments for high ...

Flow Medical expects a first-in-human case "very soon" and an IDE submission in 2027, co-founder and CEO Jennifer Fried tells ...

The study at the TCT conference in San Diego showed Boston Scientific's Watchman FLX Pro could allow for simpler blood ...

In the last two quarters, we gained share and our competitive position improved. But we believe that we have reached a ...

CEO Mike Mahoney said the upcoming years will be a time of restructuring for Boston Scientific, following layoffs and ...

Available in Europe, the Liverty TIPS stent graft helps treat the veins feeding the liver by creating a new pathway for blood ...